Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6017

Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing

$
0
0
Plus, news about United Therapeutics and Fortitude Biomedicines: 🏗️ San Diego startup licenses 'DNA construction' tech: Genyro gets exclusive rights to the technology, dubbed “Sidewinder,” which was developed by researchers at ...

Viewing all articles
Browse latest Browse all 6017

Trending Articles